Skip to content

Kronos Bio, Inc.

CIK 0001741830

← back to feed
Revenue (TTM)
$9.44M
+56.6% YoY Q1 May 2025
Net Income (TTM)
−$68.63M
+23.6% YoY Q1 May 2025
EPS Diluted (TTM)
−$1.14
+26.7% YoY Q1 May 2025
Gross Margin
—
Q1 May 2025
Operating Margin
-796.2%
Q1 May 2025
Net Margin
-726.9%
Q1 May 2025
Free Cash Flow (TTM)
−$66.67M
Q1 May 2025
Cash
$91.58M
Q1 May 2025
Total Debt
—
Q1 May 2025
Shares Outstanding
60.97M sh
Q1 May 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings